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EDITORIAL
The role of transbronchial biopsy in the diagnosis of diffuse
parenchymal lung diseases: Pro
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The diagnosis of diffuse parenchymal lung disease (DPLD)
may require invasive procedures after all noninvasive tools
have failed. The clinical context in which these diseases
develop and the radiological patterns are crucial for deﬁning
the timing and the methods to be used. After the introduc-
tion in clinical practice of High Resolution CT scan (HRCT),
the evaluation of imaging patterns, along with the immuno-
logical status of the patient and the clinical course of the
disease (acute vs. chronic) seem to be crucial in choosing the
best diagnostic procedure.1,2 In the immunocompromised
patients who develop DPLD, a prompt diagnosis is essential
for a better survival. In this circumstance, bronchoalveolar
lavage (BAL), especially when the bronchoscope is guided
by HRCT scan ﬁndings performed a few hours before, is
generally of value in diagnosing opportunistic infections,
alveolar proteinosis, alveolar hemorrhage and capillaritis,
lymphomatous or leukemic lung inﬁltration, carcinomatous
lymphangitis, disseminated hematogenous lung metastases,
hypersensitivity pneumonitis, eosinophilic pneumonitis or
diffuse alveolar damage due to drugs or radiation. In these
cases, when a conclusive diagnosis is not obtained by BAL
ﬂuid analysis or in most immunocompetent patients who
develop DPLD, transbronchial lung biopsy (TBLB) or even
open lung biopsy could be considered. The TBLB forceps
makes it possible to obtain lung tissue through the bronchial
routes and the specimens so obtained usually represent
from the centrilobular regions.3,4 Therefore, the disorders
that are centered around terminal and respiratory bron-
chioles [respiratory bronchiolitis (RB), tuberculosis, lobular
infectious pneumonia, cellular bronchiolitis] or signiﬁcantly
involve these structures (organizing pneumonia) or are
distributed along the lymphatic routes (sarcoidosis, car-
cinomatous lymphangitis) may be frequently sampled by
the forceps.4,5 In 1965, Andersen and colleagues at the
Mayo Clinic described for the ﬁrst time the rigid broncho-
scopic technique of TBLB6 and in the subsequent trials they
reported that lung tissue was obtained in 84% of patients
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doi:10.1016/j.rppneu.2011.05.003ith DPLD by using the technique of TBLB.7 The introduc-
ion of the ﬂexible bronchoscope in the late 1960s increased
he popularity of the technique and demonstrated that TBLB
ith the ﬂexible instrument may be obtained with minimal
ortality and morbidity. Currently TBLB is a well-established
iagnostic technique used by almost all bronchoscopists,
nd the ﬂexible bronchoscope is used almost exclusively.
he main complication of TBLB is bleeding; less frequent
omplications are pneumothorax, hypoxemia, or cardiac
rrhythmias during the procedure. Bleeding occurs to some
egree in virtually all TBLB procedures and it is the main
imiting factor in obtaining more or larger biopsy samples.
leeding is a major concern to the bronchoscopist because of
he limited options available to manage excessive bleeding
hrough the ﬂexible bronchoscope. The suction channel of
he typical bronchoscope is only 2mm in diameter, and the
olume of blood that can be suctioned through the channel
s therefore limited. However, to minimize the consequence
f hemorrhage by TBLB, it is possible to perform the proce-
ure using the rigid bronchoscopy and placing a non inﬂated
ogarty balloon and a rigid aspirator (4mm in diameter) in
obar bronchus near the biopsy segment. The Fogarty balloon
an be promptly inﬂated in case of bleeding. In this way it
s much easier to control the bleeding complications.8,3 The
ain utility of the TBLB rests in the possibility of making a
peciﬁc diagnosis in a patient with DPLD and avoiding a sur-
ical lung biopsy. Some studies have demonstrated that the
orphologic ﬁndings of interstitial inﬂammation and ﬁbro-
is in TBLB (such as in the diagnosis of idiopathic interstitial
neumonia) appeared to have little relevance to subse-
uent clinical course.9 While the monomorphous histological
atterns (organizing pneumonia, eosinophilic pneumonia,
iffuse alveolar damage with or without eosinophils, alve-
lar hemorrhage with or without capillaritis, alveolar
roteinosis) are easily identiﬁable in small lung fragments
but only in agreement with clinical, radiological and other
aboratory data),4,10 the tiny specimens obtained by TBLB
gia. Published by Elsevier España, S.L. All rights reserved.
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Figure 2 Transbronchial lung biopsy. Intraalveolar ﬁbrotic bud
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cryosurgical equipment operates by the Joule-Thompson
effect, which dictates that a compressed gas released at8
ay not be sufﬁcient to deﬁne the histological pattern
usual interstitial pneumonitis, desquamative interstitial
neumonitis, nonspeciﬁc interstitial pneumonitis, ﬁbros-
ng type). However, from the morphological point of view,
enerous TBLB may also provide good specimens for a diag-
osis of a pattern called nonspeciﬁc interstitial pneumonia
NSIP), cellular variant in speciﬁc clinical settings such as
olymyositis-dermatomyositis-related interstitial lung dis-
ase, drug toxicity ore in cases of unknown etiology11
lthough surgical lung biopsy is considered the best way
o obtain enough tissue to demonstrate this pattern. The
uestion of which kind of biopsy should be performed to
iagnose DPLD has a long and controversial history. Cer-
ainly, the surgical lung biopsy provides substantially more
aterial for pathological study, but the procedure requires
eneral anesthesia, and one or more days in the hospi-
al with a chest tube in place. Moreover, some reports
ave shown that this surgical procedure may be associated
ith increased mortality in certain states of the disease.
n the experience of many interstitial lung disease centers
cross the world the median mortality is 4-6% within 30
ays following surgical lung biopsy for UIP12,13 but biopsy
erformed at the time of acute exacerbation (AE) resulted
n higher 30-day mortality (28.6%) compared to non-AE.14
herefore, in recent years some studies have sought to
ncrease the diagnostic yield of transbronchial lung biopsy
n diagnosis of DPLD to avoid the surgical lung biopsy. In
his respect, Berbescu et al15 reviewed 22 patients with
nown UIP (21 cases diagnosed by surgical biopsy, 1 case
iagnosed by clinical and radiologic features) and then ret-
ospectively examined transbronchial biopsies (TBLB) from
hese patients. They concluded that a diagnosis of UIP was
ossible on the TBLB in seven subjects, and in two others
hat the ﬁndings were consistent with UIP. As a rationale
or the use of TBLB, the authors reported the high mor-
ality within 30 days following surgical lung biopsy for UIP.
owever in a critical editorial Churg and Schwarz dampened
his enthusiasm and suggested that ‘‘the collective wisdom
e followed and that TBLB should not be used to diagnose
PF/UIP’’ because the morphologic ﬁndings of interstitial
igure 1 Transbronchial lung biopsy. Diagnosis: Carcinomato-
us lymphangitis due to gastric adenocarcinoma. The lymphatics
re dilated and surrounded by neoplastic acini. Pulmonary
rtery neoplastic microangiopathy is also present.
F
oypically observed in cryptogenetic organizing pneumonia.
nﬂammation and ﬁbrosis in TBLB appeared to have lit-
le relevance to the subsequent clinical course.16 However
hat has not stopped the tenacity of other researchers in
ssessing the improved diagnostic yield using non-surgical
ethods for the histological diagnosis of ﬁbrosing diffuse
ung disease. In a study,8 we reported a signiﬁcant diag-
ostic yield and/or better preserved specimens (Fig. 1, 2)
hen TBLB were performed under general anesthesia with
igid bronchoscope using larger forceps (called Jumbo for-
eps) (Fig. 3) and without pulling them through the biopsy
hannel. Then a new way of obtaining TBLB using ﬂexi-
le cryoprobes was recently proposed (Fig. 4a, b, c). Theigure 3 Jumbo forcep with a lung sample that is poured out
f the tip of the forceps.
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RFigure 4 (a) A ﬂexible cryoprobe is shown. The metal tip, ca
biopsy obtained by ﬂexible cryoprobes with lung sample atta
specimens showing a bronchiole and lung parenchyma (interstit
high ﬂow rapidly expands and creates a very low tempera-
ture. The advantage of the cryoprobe is that large pieces of
tissue can be extracted with the freeze-thaw cycle. The ﬁrst
published data17,18 indicate that, especially in idiopathic
interstitial pneumonia, transbronchial cryobiopsy could add
important information. The size of the samples obtained
seems to increase the diagnostic yield signiﬁcantly com-
pared to forceps biopsies. Transbronchial cryobiopsies are
much larger than conventional forceps biopsies but smaller
than surgical lung biopsies. Despite having a potentially
large defect in the lung parenchyma, the occurrence of
pneumothorax and bleeding was low compared to data from
forceps biopsies. These data, therefore, indicate that the
TBLB may have even greater potential role in the diagnostic
algorithm of DLDL (even in its ﬁbrosing variants).
Furthermore, when TBLB was introduced into clinical
practice, a positive biopsy by the TBLB technique was
deﬁned as diagnostic histology, histology that supported a
diagnosis, or histology consistent with the ﬁnal diagnosis.
Indeed, most of the published reports have focused on the
diagnostic accuracy of histologic analysis of TBLB in patients
with diffuse lung disorders. In contrast there were no data
on how TBLB results are used by clinicians. In a very interest-
ing study, Ensminger and Prakash19 evaluated if the results
of the TBLB were clinically useful in the management of
patients with diffuse pulmonary disorders. In the study TBLB
was considered useful if: (a) it resulted in a speciﬁc clini-
cal diagnosis, (b) a speciﬁc management decision was made
based on the biopsy result, or (c) certain pathologic pro-
cesses were excluded on the basis of the biopsy result and
other clinical information. The results indicated that TBLB is
a clinically useful test in approximately 75% of procedures,
certainly not a negligible percentage.
In view of the above data, we believe that the use of TBLB
in the diagnosis of DLDL is useful and safe, but certainly still
too underestimated and undervalued by most clinicians. We
believe that a future topic in the study of DPLD should be a
greater implementation of the techniques of immunohisto-
chemistry, molecular biology and microarray to be applied
even on tiny samples obtained from the TBLB to increase
1visualized under ﬂuoroscopic control. (b) Transbronchial lung
to the metal tip. (c) Hematoxylin Eosin (low power). Large
ﬂammation; preserved lung architecture).
he diagnostic yield and reduce the need to refer to surgical
ung biopsy for diagnosis.
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